New York, USA – February 23, 2021 – CD Genomics has been providing the best genomics service since 2004, devoting itself to promoting the progress of genomics research. Empowered by leading technology and over a decade of experience in microbiology, CD Genomics MicrobioSeq leverages state-of-the-art sequencing platforms including Illumina, PacBio SMRT, Oxford Nanopore, and more. CD Genomics offers Microbial Whole-Genome Sequencing to address the needs of microorganism amplicon sequencing.
The microbial whole-genome sequencing platform at CD Genomics can be used to determine whole-genome assemblies, especially for repeat-dense and GC-rich genomes, as well as plasmids. Based on the resulting genomic information, it is viable to predict the functional elements of the genome, annotate gene function, conduct comparative genome studies, identify SNPs and InDels, and discover other genetic alterations among microbial strains. The platforms can be used to sequence the complete genome of bacteria, archaea, fungi, viruses, algae, and protozoa by microbial de novo sequencing or resequencing, assisting researchers in investigating the whole genome of novel or known microorganisms efficiently and economically.
More than 70% of the scientists in CD Genomics are Ph.D. and Masters-leveled, all with extensive experience in microbial genomics. They adopt an optimized rapid and efficient workflow, providing both next-generation sequencing and long-read sequencing coupled with a cloud-based platform for bioinformatics analysis.
“We will choose the most appropriate sequencing strategy and data analysis pipeline based on your sample and research purpose. With the microbial whole-genome sequencing platform, we provide bacterial whole-genome sequencing, fungal whole-genome sequencing, and viral whole-genome sequencing,” said Chief Scientist of CD Genomics. “Our services have satisfied the needs of numerous researchers.”
“Whole-genome sequencing is a handy tool for profiling gene functions of microorganisms,” said scientists from the Faculty of Health and Medical Sciences, University of Copenhagen, “we are fascinated with anti-virulence genes that exist in bacteria, which lead to the suppression of bacterial virulence. CD Genomics provided us exactly what we wanted with Illumina Genome Analyzer IIx.”
CD Genomics provides comprehensive microbial whole-genome sequencing services that cover both de novo sequencing and resequencing of a broad spectrum of microbes, including but not limited to bacteria, fungus, and viruses. CD Genomics offers the entire workflow from sample preparation to report delivery. The bioinformatics analysis covers data quality control, genome assembly, gene function annotation, functional element prediction, and comparative gene analysis. Besides basic sequencing services, CD Genomics also helps researchers put the technologies into practice-applying to human/animal health, environment, agriculture, pharma, and many other fields.
About CD Genomics
Founded in New York in 2004, CD Genomics has become one of the top providers in genomic research, providing reliable services to pharmaceutical and biotech companies as well as academia and government agencies. CD Genomics MicrobioSeq is further developed with the mission to accelerate the entire microbiome industry toward breakthrough discoveries. Through years of efforts, CD Genomics MicrobioSeq is now a leading provider of microbial sampling products, microbial testing services, microbial genomics services, and integrated bioinformatics services for hospitals, food, diagnostics, pharma, agriculture, biotechnology, and research institutes globally.